In Africa, a serious outbreak of a clade I subtype of mpox virus, previously known as monkeypox, has raised concerns about its potential spread and impact. Experts, however, are cautiously optimistic that the risk of this virus spreading in the U.S. can be mitigated by factors such as vaccination, previous immunity, lack of viral circulation in wild animals, and better healthcare and living standards.
The World Health Organization has declared mpox a global health emergency, prompting countries like Sweden and Europe to prepare for potential imported cases. While clade I is considered more severe, recent studies have shown promising results in terms of reduced mortality rates and symptom duration with better medical care and antiviral treatments.
In the U.S., authorities are monitoring the situation closely and have issued advisories for healthcare providers to screen for the clade type of mpox. With ongoing surveillance and vaccination efforts, the CDC believes that the risk of transmission, particularly among high-risk groups like men who have sex with men, can be reduced.
However, uncertainties remain about how long-lasting immunity from previous outbreaks will protect against clade I, as well as the potential for mutations that could impact the effectiveness of vaccines and treatments. As a result, experts emphasize the importance of continued vigilance and preparedness to prevent a widespread outbreak in the U.S. amidst the ongoing global health crisis caused by mpox.
Photo credit
www.nbcnews.com
